Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach.

Jose A, Kamrul-Hasan ABM, Fernandez CJ, Pappachan JM

Open source

DOI
10.5527/wjn.120295
Published
2026 Sep 25
Container
World journal of nephrology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5527/wjn.120295,
  title = {Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach.},
  author = {Jose A and Kamrul-Hasan ABM and Fernandez CJ and Pappachan JM},
  year = {2026},
  journal = {World journal of nephrology},
  doi = {10.5527/wjn.120295},
  url = {https://doi.org/10.5527/wjn.120295}
}

RIS

TY  - JOUR
TI  - Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach.
AU  - Jose A
AU  - Kamrul-Hasan ABM
AU  - Fernandez CJ
AU  - Pappachan JM
PY  - 2026
JO  - World journal of nephrology
DO  - 10.5527/wjn.120295
UR  - https://doi.org/10.5527/wjn.120295
ER  - 

APA

A, J., ABM, K., CJ, F., & JM, P. (2026). Efficacy of finerenone in reducing proteinuria in diabetic kidney disease on dapagliflozin and telmisartan: A disease-modifying approach.. World journal of nephrology. https://doi.org/10.5527/wjn.120295

Source records